Peyronies articles: review (Compilation)

[bentoboy]

Hi there,

I would like to create a list of all (or at least of the most relevant ones) academic articles/expected clinical studies/news articles etc. published in the recent years on Peyronies.

I do not know about you but for me it is super useful to have a list of all articles that have been published recently and then update it every month - just to keep track of all developments in the area.

Important Clinical trials:

• Stem Cell Treatment of Peyronie´s Disease (Denmark):
� posted: 25 February 2021; 22 participants
� expected completion: May 30, 2024
� link

• PRP for treatment of Peyronies (US):
� posted: August 23, 2020; 80 participants; randomised
� expected completion: April 1, 2024
� link

Academic articles – 2023

• January 2023:

Yang CH, Lin DY, Lin YS, Hsu CY, Tung MC, Tan KT, Ou YC. The Immunological Microenvironment and the Emerging Role of Stem Cells Therapy in Peyronie's Disease: A Systematic Narrative Review. Int J Mol Sci. 2023 Jan 1;24(1):777. doi: 10.3390/ijms24010777. PMID: 36614220; PMCID: PMC9821411.

• February 2023:

Reddy AG, Dai MC, Song JJ, Pierce HM, Patel SR, Lipshultz LI. Peyronie's Disease: An Outcomes-Based Guide to Non-Surgical and Novel Treatment Modalities. Res Rep Urol. 2023 Feb 2;15:55-67. doi: 10.2147/RRU.S278796. PMID: 36756281; PMCID: PMC9901485.

Kulkarni Y, Green B, Pattillo C, Stirland I, Flores A, Ziegelmann M, Kohler T, Helo S, Trost L. Efficacy of collagenase Clostridium histolyticum in men with congenital penile curvature. J Sex Med. 2023 Feb 14;20(2):194-199. doi: 10.1093/jsxmed/qdac006. PMID: 36763911.

Li MK, Sigalos JT, Yoffe DA, Modiri N, Hu MY, Gaither TW, Santamaria A, Walker DT, Regets KV, Mills JN, Eleswarapu SV. Multiple courses of intralesional collagenase injections for Peyronie disease: a retrospective analysis. J Sex Med. 2023 Feb 14;20(2):200-204. doi: 10.1093/jsxmed/qdac030. PMID: 36763912.

Falcone M, Preto M, Peretti F, Gontero P, Pyrgidis N, Sokolakis I, Hatzichristodoulou G. The use of collagen fleece to correct residual curvature during inflatable penile prosthesis implantation (PICS technique) in patients with complex Peyronie disease: a multicenter study. J Sex Med. 2023 Feb 14;20(2):229-235. doi: 10.1093/jsxmed/qdac003. PMID: 36763916.

Searl T, Ohlander S, McVary KT, Podlasek CA. Pathway analysis of microarray data from corpora cavernosal tissue of patients with a prostatectomy or Peyronie disease in comparison with a cavernous nerve-injured rat model of erectile dysfunction. J Sex Med. 2023 Feb 14;20(2):139-151. doi: 10.1093/jsxmed/qdac019. PMID: 36763930.

Gundogdu G, Nguyen T, Namasivayam A, Starek S, Gelman J, Mauney JR. Characterization of a novel rabbit model of Peyronie's disease. Int J Impot Res. 2023 Feb 13. doi: 10.1038/s41443-023-00671-y. Epub ahead of print. PMID: 36782023.

Spirito L, Manfredi C, La Rocca R, Napolitano L, Preto M, Di Girolamo A, Arcaniolo D, De Sio M, Creta M, Longo N. Long-term outcomes of extracorporeal shock wave therapy for acute Peyronie's disease: a 10-year retrospective analysis. Int J Impot Res. 2023 Feb 14. doi: 10.1038/s41443-023-00673-w. Epub ahead of print. PMID: 36788352.

Sicignano E, Imperatore V, Sciorio C, Di Girolamo A. The clinical potential of flavonoids in Peyronie's disease. J Basic Clin Physiol Pharmacol. 2023 Feb 15;34(2):121-123. doi: 10.1515/jbcpp-2023-0006. PMID: 36790332.

Vieiralves RR, Schuh MF, Favorito LA. Low-intensity extracorporeal shockwave therapy in the treatment of erectile dysfunction - a narrative review. Int Braz J Urol. 2023 Feb 15;49. doi: 10.1590/S1677-5538.IBJU.2023.9904. Epub ahead of print. PMID: 36794846.

Bole R, Alom M, Habashy E, Ahmed M, Ziegelmann M, Kohler T, Helo S. The clinical significance of imperfection: is idiopathic corporal asymmetry related to curvature during penile prosthesis placement? Int J Impot Res. 2023 Feb 16. doi: 10.1038/s41443-023-00669-6. Epub ahead of print. PMID: 36797455.

Kothiya AB, Adlakha N. Cellular nitric oxide synthesis is affected by disorders in the interdependent [Formula: see text] and [Formula: see text] dynamics during cystic fibrosis disease. J Biol Phys. 2023 Feb 22. doi: 10.1007/s10867-022-09624-w. Epub ahead of print. PMID: 36811722.

Brant A, Basourakos SP, Lewicki P, Kang C, Marinaro J, Punjani N, Kashanian JA. Real-world practice in Peyronie's disease management: Results from a national survey of urologists. Andrology. 2023 Feb 23. doi: 10.1111/andr.13414. Epub ahead of print. PMID: 36815582.

Schifano N, Capogrosso P, Antonini G, Baldini S, Scroppo F, Salonia A, Zerbinati N, Dehò F. The Application of Hyaluronic Acid Injections in Functional and Aesthetic Andrology: A Narrative Review. Gels. 2023 Feb 1;9(2):118. doi: 10.3390/gels9020118. PMID: 36826290; PMCID: PMC9957416.

Ziegelmann M. Is there a new role for oral therapy to treat peyronie's disease? Commentary on Daily low-dose tadalafil may reduce the penile curvature progression rate in patients with acute Peyronie's Disease: a retrospective comparative analysis. Int J Impot Res. 2023 Feb 24. doi: 10.1038/s41443-023-00684-7. Epub ahead of print. PMID: 36828955.


• March 2023:

Levine LA. What's the new thing for surgical treatment of Peyronie's disease? Extratunical grafting. J Sex Med. 2023 Mar 31;20(4):416-417. doi: 10.1093/jsxmed/qdac039. PMID: 36763947.

Ziegelmann M, Hu Y, Xiang Q, Liu G, McLane MP, Trost L. Incremental Treatment Response by Cycle With Collagenase Clostridium Histolyticum for Peyronie's Disease: A Pooled Analysis of Two Phase 3 Trials. Urology. 2023 Mar 1:S0090-4295(23)00182-6. doi: 10.1016/j.urology.2023.02.019. Epub ahead of print. PMID: 36863600.

Paulis G, Paulis A, Perletti G. Congenital penile curvature as a possible risk factor for the onset of Peyronie's disease, and psychological consequences of penile curvature. Arch Ital Urol Androl. 2023 Mar 15;95(1). doi: 10.4081/aiua.2023.11238. PMID: 36924365.

Pakpahan C, Ilhamsyah I, Supardi S, Narulita P, Agustinus A, Darmadi D. The interplay between neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, erectile dysfunction, and Peyronie's disease: A meta-analysis of observational studies. Arch Ital Urol Androl. 2023 Mar 15;95(1). doi: 10.4081/aiua.2023.11162. PMID: 36924369.

• April 2023:

Conlon WJ, Herzog BJ, Hellstrom WJG. Residual penile curvature correction by modeling during penile prosthesis implantation in Peyronie's disease patients. Int J Impot Res. 2023 Apr 13. doi: 10.1038/s41443-023-00694-5. Epub ahead of print. PMID: 37055523.

Chung E, Moon DG, Hui J, Chang HC, Hakim L, Nagao K, Tan R, Mak SK, Tantiwongse K, Lin H, Mai DBT, Nguyen Q, Tan HM, Sato Y, Jiann BP, Park K, Xin ZC, Park HJ. Clinical recommendations on penile reconstructive and prosthetic surgery: a consensus statement from the Asia-Pacific Society of Sexual Medicine. Sex Med. 2023 Apr 11;11(2):qfad003. doi: 10.1093/sexmed/qfad003. PMID: 37056790; PMCID: PMC10086569.

Thomas J, Sencaj M, Ghomeshi A, Zucker IJ, Best JC, Ramasamy R. Stem-Cell, Shockwave, and Platelet Rich Plasma Therapy for the Treatment of Erectile Dysfunction and Peyronie's Disease: A Survey of Clinics Across the US. Urology. 2023 Apr 17:S0090-4295(23)00323-0. doi: 10.1016/j.urology.2023.01.061. Epub ahead of print. PMID: 37076023.

Feng CL, Langbo WA, Anderson LK, Cao D, Bajic P, Amarasekera C, Wang V, Levine LA. Subcoronal inflatable penile prosthesis implantation: indications and outcomes. J Sex Med. 2023 Apr 19:qdad049. doi: 10.1093/jsxmed/qdad049. Epub ahead of print. PMID: 37076135.

Ilg MM, Ralph DJ, Cellek S. Statins synergize with phosphodiesterase type 5 inhibitors but not with selective estrogen receptor modulators to prevent myofibroblast transformation in an in vitro model of Peyronie's disease. J Sex Med. 2023 Apr 20:qdad051. doi: 10.1093/jsxmed/qdad051. Epub ahead of print. PMID: 37082866.

News articles:

January 2023:

• Scientists Reverse Erectile Dysfunction in Pigs Using Synthetic Tissue Link

February 2023:

• Endo Launches "Man With a Plan" Campaign to Support Men With Symptoms of Peyronie's Disease Link

April  2023:

• Early-onset diabetes appears to affect Peyronie disease severity  Link

[FrankPD]

It's nice to know there's that many studies.  If felt nearly nonexistent to me even after being 16 months since diagnosis.  Most don't even know this exists.  

Thanks!

[bentoboy]

Not many new articles for May. Here you go anyway:

May 2023

Paulis G, Paulis A. Chronic prostatitis as possible risk factor for Peyronie's disease: Psychological, sexual and prostatitis-like symptoms in patients with Peyronies Disease. Arch Ital Urol Androl. 2023 May 31:11406. doi: 10.4081/aiua.2023.11406. Epub ahead of print. PMID: 37259816.

Henry AJ, Holler JT, Lui J, Breyer BN, Ziegelmann M, Cohen T, Smith RP, Yeaman C, Winkelman AJ, Villanueva C, Kern NG. Do patients with Peyronie's disease perceive penile curvature in adults and children differently than the general population? J Sex Med. 2023 Jun 2:qdad073. doi: 10.1093/jsxmed/qdad073. Epub ahead of print. PMID: 37279444.

[bentoboy]

June 2023

Wilson SK, Wen L, Rossello M, Maria P, Carrion R, Perito P, Ralph D, Antonini G, Carvajal A, Ozturk MI, Chung E. Initial safety outcomes for the Rigicon Infla10® inflatable penile prosthesis. BJU Int. 2023 Jun;131(6):729-733. doi: 10.1111/bju.15960. Epub 2023 Mar 6. PMID: 36633050.

Kothiya AB, Adlakha N. Cellular nitric oxide synthesis is affected by disorders in the interdependent [Formula: see text] and [Formula: see text] dynamics during cystic fibrosis disease. J Biol Phys. 2023 Jun;49(2):133-158. doi: 10.1007/s10867-022-09624-w. Epub 2023 Feb 22. PMID: 36811722; PMCID: PMC10160313.

Mitsui Y, Yamabe F, Hori S, Uetani M, Kobayashi H, Nagao K, Nakajima K. Molecular Mechanisms and Risk Factors Related to the Pathogenesis of Peyronie's Disease. Int J Mol Sci. 2023 Jun 14;24(12):10133. doi: 10.3390/ijms241210133. PMID: 37373277; PMCID: PMC10299070.

Lee HY, Pyun JH, Shim SR, Kim JH. Medical Treatment for Peyronie's Disease: Systematic Review and Network Bayesian Meta-Analysis. World J Mens Health. 2023 Jun 15. doi: 10.5534/wjmh.230016. Epub ahead of print. PMID: 37382281.

Khooblall P, Bole R, Lundy SD, Bajic P. Expanded Utilization of Intralesional Therapies for Treatment of Peyronie's Disease. Res Rep Urol. 2023 Jun 21;15:205-216. doi: 10.2147/RRU.S386340. PMID: 37366388; PMCID: PMC10290860.

Ilg MM, Ralph DJ, Cellek S. Statins synergize with phosphodiesterase type 5 inhibitors but not with selective estrogen receptor modulators to prevent myofibroblast transformation in an in vitro model of Peyronie's disease. J Sex Med. 2023 Jun 28;20(7):925-934. doi: 10.1093/jsxmed/qdad051. PMID: 37082866.

Henry AJ, Holler JT, Lui J, Breyer BN, Ziegelmann M, Cohen T, Smith RP, Yeaman C, Winkelman AJ, Villanueva C, Kern NG. Do patients with Peyronie's disease perceive penile curvature in adults and children differently than the general population? J Sex Med. 2023 Jun 28;20(7):998-1003. doi: 10.1093/jsxmed/qdad073. PMID: 37279444.

Bole R, Bajic P. Editorial CommentRe: Stem-Cell, Shockwave, and Platelet Rich Plasma Therapy for the Treatment of Erectile Dysfunction and Peyronie's Disease: A Survey of Clinics Across the USA. Urology. 2023 Jun 30:S0090-4295(23)00325-4. doi: 10.1016/j.urology.2023.01.062. Epub ahead of print. PMID: 37394358.

July 2023

Roadman D, Wang V, Langbo W, Paddock D, Levine L. Predictors of hinge effect in patients with Peyronie's disease. J Sex Med. 2023 Jul 17:qdad087. doi: 10.1093/jsxmed/qdad087. Epub ahead of print. PMID: 37460401.

Rosenberg JE, Ergun O, Hwang EC, Risk MC, Jung JH, Edwards ME, Blair Y, Dahm P. Non-surgical therapies for Peyronie's disease. Cochrane Database Syst Rev. 2023 Jul 17;7(7):CD012206. doi: 10.1002/14651858.CD012206.pub2. PMID: 37490423; PMCID: PMC10351344.

Roadman D, Wang V, Beer A, Levine L. A contemporary assessment of the evaluation and management of patients presenting to a tertiary medical center with Peyronie's disease. Int J Impot Res. 2023 Jul 19. doi: 10.1038/s41443-023-00738-w. Epub ahead of print. PMID: 37468535.

Rahardjo HE, Märker V, Tsikas D, Kuczyk MA, Ückert S, Bannowsky A. Fibrotic Diseases of the Human Urinary and Genital Tract: Current Understanding and Potential Strategies for Treatment. J Clin Med. 2023 Jul 19;12(14):4770. doi: 10.3390/jcm12144770. PMID: 37510885; PMCID: PMC10381287.

Osman MM, Hammad MA, Barham DW, Toma R, El-Khatib FM, Dianatnejad S, Nguyen J, Towe M, Choi E, Wu Q, Banavar G, Cai Y, Moura P, Shen N, Vuyisich M, Yafi NR, Yafi FA. Comparison of the gut microbiome composition between men with Peyronie's disease and a matched cohort: a pilot study. Int J Impot Res. 2023 Jul 20. doi: 10.1038/s41443-023-00737-x. Epub ahead of print. PMID: 37474796.

Dell'Atti L, Ronchi P. Low-intensity laser diode plus extracorporeal shock wave therapy: a new treatment strategy in the management of Peyronie's disease. World J Urol. 2023 Jul 25. doi: 10.1007/s00345-023-04533-6. Epub ahead of print. PMID: 37490060.

Park SH, Wilson SK, Wen L. Subcoronal Incision for Inflatable Penile Prosthesis Does Not Risk Glans Necrosis. J Urol. 2023 Jul 25:101097JU0000000000003619. doi: 10.1097/JU.0000000000003619. Epub ahead of print. PMID: 37490615.

August 2023

Schifano N, Capogrosso P, Boeri L, Fallara G, Chiappini S, Rewhorn M, Cakir OO, Harvey H, Castiglione F, Alnajjar HM, Muneer A, Deho' F, Schifano F, Montorsi F, Salonia A. Are finasteride-related penile curvature/Peyronie's disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases. Int J Impot Res. 2023 Aug;35(5):465-471. doi: 10.1038/s41443-022-00568-2. Epub 2022 May 5. PMID: 35513712.

[bentoboy]

September

Low P, Wang L, Li KD, Shibley WP, Cedars BE, Holler JT, Enriquez A, Sadeghi-Nejad H, Amend GM, Breyer BN. Thematic analysis of the psycho-sexual symptoms in patients with Peyronie's disease present on online forums. Int J Impot Res. 2023 Sep;35(6):533-538. doi: 10.1038/s41443-022-00589-x. Epub 2022 Jun 16. PMID: 35710605; PMCID: PMC10499595.

Sischka M, Krueger A, Parikh N, Kohler T, Helo S, Ziegelmann M. Significant Geographic Variation in Access to Certified Collagenase Clostridium histolyticum Injectors for Peyronie's Disease Throughout the United States. Urol Pract. 2023 Sep 7:101097UPJ0000000000000456. doi: 10.1097/UPJ.0000000000000456. Epub ahead of print. PMID: 37788391.

Wang X, Liu H, Tang G, Wu G, Chu Y, Wu J, Cui Y. Updated recommendations on the therapeutic role of extracorporeal shock wave therapy for peyronie's disease: systematic review and meta-analysis. BMC Urol. 2023 Sep 12;23(1):145. doi: 10.1186/s12894-023-01320-8. PMID: 37700253; PMCID: PMC10498627.

Paulis G, Paulis A. Benign prostatic obstruction (BPO) as a possible risk factor for Peyronie's disease (Peyronies Disease). The influence of BPO and Peyronies Disease on mental health. Arch Ital Urol Androl. 2023 Sep 12;95(3):11481. doi: 10.4081/aiua.2023.11481. PMID: 37791559.

Tomioka M, Uno H, Seike K, Iinuma K, Tatsuhiko M. A Case Report of Syphilis That Was Difficult to Distinguish From Penile Carcinoma. Cureus. 2023 Sep 11;15(9):e45029. doi: 10.7759/cureus.45029. PMID: 37829948; PMCID: PMC10566309.

October

Ziegelmann MJ. Penile indentation and hourglass deformities with Peyronie's disease-what can we reasonably offer our patients? J Sex Med. 2023 Oct 3;20(10):1230-1232. doi: 10.1093/jsxmed/qdad105. PMID: 37784214.

Green B, Flores A, Warner J, Kohler T, Helo S, Trost L. Comparison of Collagenase Clostridium histolyticum to Surgery for the Management of Peyronie's Disease: A Randomized Trial. J Urol. 2023 Nov;210(5):791-802. doi: 10.1097/JU.0000000000003634. Epub 2023 Oct 9. PMID: 37811752.

[bentoboy]

October

Dell'Atti L, Slyusar V, Ronchi P. Serum Testosterone Concentration Influences the Response to Extracorporeal Shock Wave Treatment in Men With Peyronie's Disease. Urology. 2023 Oct 11:S0090-4295(23)00881-6. doi: 10.1016/j.urology.2023.09.037. Epub ahead of print. PMID: 37832829.

Cai T, Capece M, Ceruti C, Tiscione D, Puglisi M, Verze P, Gontero P, Palmieri A. The Use of Vacuum Devices as Adjuvant Therapy before and after Penile Curvature Surgery in Patients Affected by La Peyronie's Disease: Results from a Comparative Study. Clin Pract. 2023 Oct 17;13(5):1244-1252. doi: 10.3390/clinpract13050112. PMID: 37887088; PMCID: PMC10605300.

Kraglund R, Durukan E, Giraldi A, Fode M. The association between Peyronie's disease and depression: a scoping review. Sex Med Rev. 2023 Oct 28:qead045. doi: 10.1093/sxmrev/qead045. Epub ahead of print. PMID: 37902293.

Preto M, Falcone M, Plamadeala N, Schifano N, Bettocchi C, Colombo F, Fiordelise S, Vitarelli A, Silvani M, Mondaini N, Paradiso M, Ceruti C, Varvello F, Palumbo F, Avolio A, Antonini G, Corvasce A, Pozza D, Franco G, Bitelli M, Boezio F, Conti E, Caraceni E, Negro C, Carrino M, Vicini P, Ghidini N, Alei G, Italiano E, Timpano M, Polito M, Natali A, Tamai A, Pescatori E, Dehò F, Gideon B, Gontero P, Palmieri A, Capogrosso P. Risk of unfavorable outcomes after penile prosthesis implantation - results from a national registry (INSIST-Erectile Dysfunction). Int J Impot Res. 2023 Oct 31. doi: 10.1038/s41443-023-00784-4. Epub ahead of print. PMID: 37907669.

Pyrgidis N, Sokolakis I, Hatzichristodoulou G. Intermediate-term results of TachoSil grafting to correct residual curvature during inflatable penile prosthesis implantation in patients with Peyronie's disease. Int J Impot Res. 2023 Nov;35(7):647-650. doi: 10.1038/s41443-023-00708-2. Epub 2023 May 5. PMID: 37147483.

November

Green B, Flores A, Warner J, Kohler T, Helo S, Trost L. Comparison of Collagenase Clostridium histolyticum to Surgery for the Management of Peyronie's Disease: A Randomized Trial. J Urol. 2023 Nov;210(5):791-802. doi: 10.1097/JU.0000000000003634. Epub 2023 Oct 9. PMID: 37811752.

Chung E, Blecher G. Perspective: Residual penile curvature correction during penile prosthesis implantation by plication in Peyronie's patients. Int J Impot Res. 2023 Nov;35(7):643-646. doi: 10.1038/s41443-023-00774-6. Epub 2023 Oct 20. PMID: 37864087; PMCID: PMC10622317.

Cevik G, Tozsin A, Tastekin E, Dursun M, Aktoz T, Kadioglu A. The Effect of Pirfenidone on Peyronie Plaques and Erectile Function in a Peyronie's Rat Model. J Coll Physicians Surg Pak. 2023 Nov;33(11):1217-1222. doi: 10.29271/jcpsp.2023.11.1217. PMID: 37926870.

Zucker I, Nackeeran S, Mirza S, Masterson TA. Risk Factors for Penile Fracture After Intralesional Collagenase Clostridium histolyticum in Peyronie's Disease. Urology. 2023 Nov 8:S0090-4295(23)00990-1. doi: 10.1016/j.urology.2023.10.019. Epub ahead of print. PMID: 37949243.

Lehner K, Byrne E, Roshandel MR, Alom M, Helo S, Köhler T, Ziegelmann M. The Discontinuation Rate With Collagenase Clostridium histolyticum for Peyronie's Disease in a High-volume Practice Is Unexpectedly High: Identifying Opportunities for Patient Care Improvement. Urology. 2023 Nov 8:S0090-4295(23)00992-5. doi: 10.1016/j.urology.2023.10.022. Epub ahead of print. PMID: 37949244.

Zhao S, Wu X, Zhang Y, Zhang C. Role of Shear Wave Elastography in the Diagnosis of Peyronie Disease. J Ultrasound Med. 2023 Nov 10. doi: 10.1002/jum.16372. Epub ahead of print. PMID: 37948532.

Capogrosso P, Pozzi E, Russo GI, Hatzichristodoulou G, Cocci A, Falcone M, Martinez-Salamanca JI, Fernández-Pascual E, Candela L, Schifano N, Dehò F, Salonia A; European Association of Urology–Young Academic Urologists Sexual and Reproductive Working Group. Patients' attitude with surgery for Peyronie's disease: results from a multicentric European study. J Sex Med. 2023 Nov 16:qdad145. doi: 10.1093/jsxmed/qdad145. Epub ahead of print. PMID: 37973410.

Lee WG, Gordon P, Ralph D. Lightweight macroporous mesh can be used for corporal reconstruction during penile prosthesis surgery. J Sex Med. 2023 Nov 30;20(12):1446-1450. doi: 10.1093/jsxmed/qdad134. PMID: 37818830.

Almsaoud NA, Safar O, Alshahrani ST, Alwadai R, Alkhaldi SM, Almurayyi M, Alrweili HH, Assiri HM, Al Jubran A, Hakami B, Alzahrani MA. The effect of penile traction device in men with Peyronie's disease on penile curvature, penile length, and erectile dysfunction: a systematic review and meta-analysis. Transl Androl Urol. 2023 Nov 30;12(11):1673-1685. doi: 10.21037/tau-23-310. Epub 2023 Nov 9. PMID: 38106680; PMCID: PMC10719764.

Kianian R, Andino JJ, Morrison JJ, Grundy D, Appleton A, Lavold AJ, Eleswarapu SV, Mills JN. Potential primary prevention of Peyronie's disease post prostatectomy?-retrospective analysis of peri-operative multi-modal penile rehabilitation. Transl Androl Urol. 2023 Nov 30;12(11):1708-1712. doi: 10.21037/tau-23-281. Epub 2023 Nov 23. PMID: 38106686; PMCID: PMC10719776.

[bentoboy]

December

Pinkhasov AM, Beamer M, Shulman D, Yakubov R, Pinkhasov E, Kravchick S. A novel technique for unilateral dissection of the penile neurovascular bundle to prevent loss of penile sensation during treatment of Peyronie's disease-Initial results of a pilot study. Curr Urol. 2023 Dec;17(4):299-302. doi: 10.1097/CU9.0000000000000209. Epub 2023 Jun 8. PMID: 37994333; PMCID: PMC10662816.

Larson H, Warner J, Savage J, Kohler T, Ziegelmann M, Trost L. Changes in Point of Maximal Curvature During Collagenase Clostridium Histolyticum Injections for Peyronie's Disease. Urology. 2023 Dec 5:S0090-4295(23)01018-X. doi: 10.1016/j.urology.2023.11.024. Epub ahead of print. PMID: 38061610.

Langbo WA, Wang V, Bajic P, Levine L. Long-term outcomes after plaque excision grafting for Peyronie's disease and subanalysis of patients who undergo the procedure despite preoperative counseling against it. J Sex Med. 2023 Dec 12:qdad164. doi: 10.1093/jsxmed/qdad164. Epub ahead of print. PMID: 38087916.

Karakose A, Yitgin Y. A new alternative approach to management of acute phase Peyronie's disease: low intensity extracorporeal shockwave therapy and platelet-rich plasma. Minerva Urol Nephrol. 2023 Dec 13. doi: 10.23736/S2724-6051.23.05458-7. Epub ahead of print. PMID: 38093617.

Alzahrani MA. Penile Mondor's Disease Resulting From Forceful Condom Removal During Sexual Intercourse: A Case Report and Literature Review. Cureus. 2023 Dec 20;15(12):e50872. doi: 10.7759/cureus.50872. PMID: 38130908; PMCID: PMC10733711.

Larson H, Savage J, Brearton K, Warner R, Ziegelmann M, Kohler T, Trost L. Outcomes of collagenase Clostridium histolyticum in men with ventral curvatures: an updated series. J Sex Med. 2023 Dec 22:qdad167. doi: 10.1093/jsxmed/qdad167. Epub ahead of print. PMID: 38141054.

[bentoboy]

January


Falcone M, Preto M, Morgado AR, Sokolakis I, Sarıkaya S, Capece M, Capogrosso P, Manfredi C, Tsampoukas G, Russo G. Risk and benefits of penile length preservation techniques during penile prosthesis implantation: a systematic review by the young academic urologists sexual and reproductive health working group. Ther Adv Urol. 2024 Jan 8;16:17562872231215177. doi: 10.1177/17562872231215177. PMID: 38205393; PMCID: PMC10775725.

Natsos A, Tatanis V, Kontogiannis S, Waisbrod S, Gkeka K, Obaidad M, Peteinaris A, Pagonis K, Papadopoulos C, Kallidonis P, Liatsikos E, Drettas P. Grafts in Peyronie's surgery without the use of prostheses: a systematic review and meta-analysis. Asian J Androl. 2024 Jan 9. doi: 10.4103/aja202358. Epub ahead of print. PMID: 38265253.

Durukan E, Kraglund R, Rashid SA, Thorkilgaard T, Jensen CFS, Fode M. Phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie's Disease: A retrospective cohort study. Int J Impot Res. 2024 Jan 16. doi: 10.1038/s41443-023-00810-5. Epub ahead of print. PMID: 38228873.

Dell'Atti L, Slyusar V, Ronchi P. Serum Testosterone Concentration Influences the Response to Extracorporeal Shock Wave Treatment in Men With Peyronie's Disease. Urology. 2024 Jan;183:111-116. doi: 10.1016/j.urology.2023.09.037. Epub 2023 Oct 11. PMID: 37832829.

Langbo WA, Wang V, Bajic P, Levine L. Long-term outcomes after plaque excision grafting for Peyronie's disease and subanalysis of patients who undergo the procedure despite preoperative counseling against it. J Sex Med. 2024 Jan 30;21(2):163-168. doi: 10.1093/jsxmed/qdad164. PMID: 38087916.

Zucker I, Nackeeran S, Mirza S, Masterson TA. Risk Factors for Penile Fracture After Intralesional Collagenase Clostridium histolyticum in Peyronie's Disease. Urology. 2024 Jan;183:117-120. doi: 10.1016/j.urology.2023.10.019. Epub 2023 Nov 8. PMID: 37949243.

Paulis G, Paulis A, De Giorgio G, Quattrocchi S. Measurement of Oxidative Stress Index (OSI) in Penile Corpora Cavernosa and Peripheral Blood of Peyronie's Disease Patients: A Report of 49 Cases. Metabolites. 2024 Jan 15;14(1):55. doi: 10.3390/metabo14010055. PMID: 38248858; PMCID: PMC10821449.

Giagulli VA, Lisco G, De Tullio A, Guastamacchia E, Triggiani V, Jirillo E. The pathogenic role of the immune system in erectile dysfunction and Peyronie's disease: focusing on immunopathophysiology and potential therapeutic strategies. Sex Med Rev. 2024 Jan 9:qead055. doi: 10.1093/sxmrev/qead055. Epub ahead of print. PMID: 38196188.

Podlasek CA. Nanotechnology in sexual medicine. J Sex Med. 2024 Jan 30;21(2):81-83. doi: 10.1093/jsxmed/qdad149. PMID: 38314625; PMCID: PMC10839571.

Cilio S, Rocca R, Celentano G, Marino C, Creta M, Califano G, Manfredi C, Russo GI, Morgado A, Falcone M, Capece M; YAU Working Group Sexual and Reproductive Health. Intraplaque injections of hyaluronic acid for the treatment of stable-phase Peyronie's disease: a retrospective single-center experience. Asian J Androl. 2024 Feb 2. doi: 10.4103/aja202371. Epub ahead of print. PMID: 38305689.

Moraes Braga C, Cantilino A. An unwelcome third party: the role of inflammation in the relationship between depression and Peyronie's disease. Sex Med Rev. 2024 Feb 1:qeae002. doi: 10.1093/sxmrev/qeae002. Epub ahead of print. PMID: 38303665.

Twidwell J, Mahon J, Tortorelis D, Levine L. Transdermal application of H100 gel to the penile shaft in patients with Peyronie's disease infiltrates the tunica albuginea. Int J Impot Res. 2024 Jan 13. doi: 10.1038/s41443-023-00819-w. Epub ahead of print. PMID: 38218956.

[bentoboy]

February

Larson H, Warner J, Savage J, Kohler T, Ziegelmann M, Trost L. Changes in Point of Maximal Curvature During Collagenase Clostridium Histolyticum Injections for Peyronie's Disease. Urology. 2024 Feb;184:122-127. doi: 10.1016/j.urology.2023.11.024. Epub 2023 Dec 6. PMID: 38061610.


Cilio S, Rocca R, Celentano G, Marino C, Creta M, Califano G, Manfredi C, Russo GI, Morgado A, Falcone M, Capece M; YAU Working Group Sexual and Reproductive Health. Intraplaque injections of hyaluronic acid for the treatment of stable-phase Peyronie's disease: a retrospective single-center experience. Asian J Androl. 2024 Feb 2. doi: 10.4103/aja202371. Epub ahead of print. PMID: 38305689.


Wang X, Bao X, Liu H, Cui Y. Exploring the pharmacological mechanism of Herba Epimedii (yinyanghuo) for Peyronie's disease with network pharmacology strategy. Asian J Surg. 2024 Feb 20:S1015-9584(24)00270-7. doi: 10.1016/j.asjsur.2024.02.012. Epub ahead of print. PMID: 38383197.

Garaffa G, Traunero F, Claps F, Pavan N, Rossin G, Piasentin A, Rizzo M, Biasatti A, Zorzi F, Trombetta C, Liguori G, Ongaro L. Plication surgery does not produce additional loss of length in Peyronie's disease patients. Int J Impot Res. 2024 Feb 22. doi: 10.1038/s41443-024-00852-3. Epub ahead of print. PMID: 38388784.

Levine LA, Desouky E, Elist JJ, Moon D, Wilson SK. Use of Himplant® for correction of residual deformity following prior treatment of peyronie's disease: a case series. Int J Impot Res. 2024 Feb 23. doi: 10.1038/s41443-024-00840-7. Epub ahead of print. PMID: 38388785.

Ledesma BR, Velasquez DA, Egemba C, Molina M, Ibrahim E, Costantini-Mesquita F, Deebel NA, Han S, Reis IM, Saltzman R, Ramasamy R. A phase 2 randomized, placebo-controlled crossover trial to evaluate safety and efficacy of platelet-rich plasma injections for Peyronie's disease: clinical trial update. Int J Impot Res. 2024 Feb 29. doi: 10.1038/s41443-024-00844-3. Epub ahead of print. PMID: 38424354.


March

Thach S, Pommier B, Soulier V. The impact of Peyronie's disease on couples. Fr J Urol. 2024 Mar 4;34(4):102595. doi: 10.1016/j.fjurol.2024.102595. Epub ahead of print. PMID: 38442548.

Rassweiler JJ, Scheitlin W, Goezen AS, Radecke F. Long-term experiences with high-energy shock wave therapy in the management chronic phase Peyronie's disease using two different electromagnetic lithotripters. World J Urol. 2024 Mar 7;42(1):124. doi: 10.1007/s00345-024-04792-x. PMID: 38453751; PMCID: PMC10920406.

Şahin A, Babayev H, Cirigliano L, Preto M, Falcone M, Altıntas E, Gül M. Unveiling the molecular Hallmarks of Peyronie's disease: a comprehensive narrative review. Int J Impot Res. 2024 Mar 7. doi: 10.1038/s41443-024-00845-2. Epub ahead of print. PMID: 38454161.

Institute for Quality and Efficiency in Health Care (IQWiG). Penile traction therapy for induratio penis plastica: IQWiG Reports – Commission No. N22-01 [Internet]. Cologne (Germany): Institute for Quality and Efficiency in Health Care (IQWiG); 2024 Mar 8. PMID: 38574187.

Hatzichristodoulou G, Gültekin MH, Özkara H, Akkus E. First worldwide correction of ventral Peyronie's disease utilizing rigicon inflatable penile prosthesis combined with plaque incision & grafting with collagen fleece (PICS-technique) for residual curvature. Int J Impot Res. 2024 Mar 13. doi: 10.1038/s41443-024-00873-y. Epub ahead of print. PMID: 38480871.

Jin DC, Luo Y, Wang P, Zhang Y, Bi G, Tong DL, Wang YY, Zhou WY, Li YF. Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease. J Vis Exp. 2024 Mar 15;(205). doi: 10.3791/66305. PMID: 38557978.

Paulis G, De Giorgio G, Paulis A. Ultrasound Elastography as a Diagnostic Tool for Peyronie's Disease: A State-of-the-Art Review. Diagnostics (Basel). 2024 Mar 21;14(6):665. doi: 10.3390/diagnostics14060665. PMID: 38535085; PMCID: PMC10969672.

Giagulli VA, Lisco G, De Tullio A, Guastamacchia E, Triggiani V, Jirillo E. The pathogenic role of the immune system in erectile dysfunction and Peyronie's disease: focusing on immunopathophysiology and potential therapeutic strategies. Sex Med Rev. 2024 Mar 26;12(2):210-220. doi: 10.1093/sxmrev/qead055. PMID: 38196188.

"This study is to our knowledge the first analysis of temporal gene expression associated with the regulation of the transformation of resident fibroblasts to profibrotic myofibroblasts in Peyronies Disease. Further research is warranted to investigate the role of the MAPK-Hedgehog signaling pathways in reversibility of Peyronies Disease.'

Spirito L, Manfredi C, La Rocca R, Napolitano L, Di Girolamo A, Capece M, Trama F, Sciorio C, Sokolakis I, Creta M, Arcaniolo D. Daily low-dose tadalafil may reduce the penile curvature progression rate in patients with acute Peyronie's disease: a retrospective comparative analysis. Int J Impot Res. 2024 Apr;36(2):129-134. doi: 10.1038/s41443-022-00651-8. Epub 2022 Dec 13. PMID: 36513814.

[bentoboy]

April

Spirito L, Manfredi C, La Rocca R, Napolitano L, Preto M, Di Girolamo A, Arcaniolo D, De Sio M, Creta M, Longo N. Long-term outcomes of extracorporeal shock wave therapy for acute Peyronie's disease: a 10-year retrospective analysis. Int J Impot Res. 2024 Apr;36(2):135-139. doi: 10.1038/s41443-023-00673-w. Epub 2023 Feb 14. PMID: 36788352.

Maremanda AP, Du Comb W, Able C, Kohn TP, Unal S, Burnett AL. Erectile dysfunction and Peyronie's disease diagnosis rates after penile fracture-a retrospective claims database cohort analysis. Int J Impot Res. 2024 Apr;36(2):125-128. doi: 10.1038/s41443-023-00746-w. Epub 2023 Aug 4. PMID: 37542153.

Zugail AS, Alshuaibi M, Lombion S, Beley S. Safety and feasibility of percutaneous needle tunneling with platelet-rich plasma injections for Peyronie's disease in the outpatient setting: a pilot study. Int J Impot Res. 2024 Apr;36(2):140-145. doi: 10.1038/s41443-023-00744-y. Epub 2023 Aug 7. PMID: 37550385.

Loloi J, Schuppe K, Reddy RV, Rahman F, Bernstein A, Reddy P, Kulkarni N, Masterson T, Ramasamy R. A survey of exposure to the use of Xiaflex for the treatment of Peyronie's disease among United States urology residency programs. Int J Impot Res. 2024 Apr;36(2):155-159. doi: 10.1038/s41443-023-00781-7. Epub 2023 Oct 21. PMID: 37865716.

Kadıoğlu A, Gürcan M, Rakhmonovich AF, Dursun M. Surgical management of complex curvature in Peyronie's disease. World J Urol. 2024 Apr 30;42(1):276. doi: 10.1007/s00345-024-04936-z. PMID: 38689034; PMCID: PMC11061042.

Schneider D, O'Leary M, Amini E, Miller J, Hassas N, Nguyen J, Hammad MAM, Barham D, Yafi FA. Peyronie's disease response to intralesional collagenase clostridium histolyticum therapy is independent of baseline testosterone. Andrology. 2024 May;12(4):830-834. doi: 10.1111/andr.13532. Epub 2023 Sep 27. PMID: 37753943.

[bentoboy]

April

Spinozzi L, Droghetti M, Palmisano F, Piazza P, Fontanella L, Gentile G, Franceschelli A, Colombo F. Use of Soft Penile Prosthesis in Grafting Surgery for Peyronie's Disease and Mild Erectile Dysfunction: Still an Option? Arch Esp Urol. 2024 Apr;77(3):270-277. doi: 10.56434/j.arch.esp.urol.20247703.36. PMID: 38715168.


Roadman D, Feng C, Salkowski M, Levine LA. A contemporary systematic review of penile lengthening procedures with penile prosthesis. Transl Androl Urol. 2024 Apr 30;13(4):596-612. doi: 10.21037/tau-23-354. Epub 2024 Apr 18. PMID: 38721300; PMCID: PMC11074682.

May

Cosentino M, Di Nauta M, Boeri L, Ferraioli G, Lucignani G, Ricapito A, Gadda F, Iafrate M, Mancini M, Dal Moro F, Ruiz-Castañe E, Bettocchi C, Montanari E, Sofikitis N. Conservative treatment of Peyronie's disease: a guide. World J Urol. 2024 May 13;42(1):317. doi: 10.1007/s00345-024-04975-6. PMID: 38740620.

Tienforti D, Hoxha M, Di Pasquale AB, Rizza V, Barbonetti A. Analysis of evidence on nutraceutical interventions for Peyronie's disease: a guideline-based critical review. Sex Med Rev. 2024 May 28:qeae038. doi: 10.1093/sxmrev/qeae038. Epub ahead of print. PMID: 38807529.


Asmundo MG, Durukan E, von Rohden E, Thy SA, Jensen CFS, Fode M. Platelet-rich plasma therapy in erectile dysfunction and Peyronie's disease: a systematic review of the literature. World J Urol. 2024 May 29;42(1):359. doi: 10.1007/s00345-024-05065-3. PMID: 38811395; PMCID: PMC11136842.


Ilg MM, Bustin SA, Ralph DJ, Cellek S. TGF-β1 induces formation of TSG-6-enriched extracellular vesicles in fibroblasts which can prevent myofibroblast transformation by modulating Erk1/2 phosphorylation. Sci Rep. 2024 May 29;14(1):12389. doi: 10.1038/s41598-024-62123-x. PMID: 38811625; PMCID: PMC11136978.


Kolanukuduru KP, Mandel AL, Simhal RK, Sholklapper TN, Sun K, Poluch M, Wang KR, Shah YB, Chung PH. Marfan's syndrome is associated with a greater risk of Peyronie's disease: a case-control study of the TriNetX database. Int J Impot Res. 2024 May 30. doi: 10.1038/s41443-024-00923-5. Epub ahead of print.PMID: 38816576.


Ceballos B, Baumgarten AS, Krug AM, Morey AF. Extratunical grafting for minimally invasive management of complex Peyronie's disease deformities. J Sex Med. 2024 May 28;21(6):579-581. doi: 10.1093/jsxmed/qdae049. PMID: 38825575.


Wang W, Wan F, Yu T, Wu S, Cui X, Xiang C, Li M, Liu Q, Lin C. Microvesicles-delivering Smad7 have advantages over microvesicles in suppressing fibroblast differentiation in a model of Peyronie's disease. BMC Biotechnol. 2024 Jun 7;24(1):40. doi: 10.1186/s12896-024-00866-1. PMID: 38849776; PMCID: PMC11162046.


Dell'Atti L, Slyusar V, Cambise C. Multimodal treatments based on Tadalafil during acute phase of Peyronie's disease: experience at two referral academic centers. Ir J Med Sci. 2024 Jun 11. doi: 10.1007/s11845-024-03734-1. Epub ahead of print. PMID: 38861101.

[alharami333]

great information

[bentoboy]

June

Karakose A, Yitgin Y. A new alternative approach to management of acute phase Peyronie's disease: low intensity extracorporeal shockwave therapy and platelet-rich plasma. Minerva Urol Nephrol. 2024 Jun;76(3):367-372. doi: 10.23736/S2724-6051.23.05458-7. Epub 2023 Dec 13. PMID: 38093617.

Lledó García E, González García FJ, Jara Rascón J, García Muñoz J, Lledó Graell E, Sánchez Ochoa MA, Hernández Fernández C. Satisfaction assessment study in patients (and their partners) with/without Peyronie's disease and penile prosthesis implantation. Actas Urol Esp (Engl Ed). 2024 Jun;48(5):392-397. English, Spanish. doi: 10.1016/j.acuroe.2024.02.003. Epub 2024 Feb 15. PMID: 38367908.

Wang X, Bao X, Liu H, Cui Y. Exploring the pharmacological mechanism of Herba Epimedii (yinyanghuo) for Peyronie's disease with network pharmacology strategy. Asian J Surg. 2024 Jun;47(6):2862-2863. doi: 10.1016/j.asjsur.2024.02.012. Epub 2024 Feb 20. PMID: 38383197.

Baudry A, Schirmann A, Guillot-Tantay C, Lebret T, Vidart A, Neuville P, Madec FX. 50 years of inflatable penile implants: Where do we stand in France? Fr J Urol. 2024 Jun;34(5):102635. doi: 10.1016/j.fjurol.2024.102635. Epub 2024 Apr 8. PMID: 38599322.

Wang W, Wan F, Yu T, Wu S, Cui X, Xiang C, Li M, Liu Q, Lin C. Microvesicles-delivering Smad7 have advantages over microvesicles in suppressing fibroblast differentiation in a model of Peyronie's disease. BMC Biotechnol. 2024 Jun 7;24(1):40. doi: 10.1186/s12896-024-00866-1. PMID: 38849776; PMCID: PMC11162046.

Moncada I, Krishnappa P, Zaccaro C, Fraile A, Romero-Otero J, Martinez-Salamanca JI, Lledó-Garcia E. Penile prosthesis implantation is safe and effective in Peyronie's disease patients with and without erectile dysfunction. Int J Impot Res. 2024 Jun 22. doi: 10.1038/s41443-024-00938-y. Epub ahead of print. PMID: 38909107.

Candido P, Pimenta R, Maluf FC, Chiovatto C, Romão P, Baldavira CM, Ghazarian V, Camargo JA, Guimarães VR, Santos GAD, Silva IA, Nascimento B, Hallak J, Capelozzi VL, Srougi M, Nahas WC, Viana NI, Leite KR, Reis ST. MicroRNA-29b attenuates fibrosis in a rat model of Peyronie's disease. Andrology. 2024 Jun 24. doi: 10.1111/andr.13672. Epub ahead of print. PMID: 38925608.

Chi J, Bi W, Lou K, Ma J, Wu J, Cui Y. Research advances in Peyronie's disease: a comprehensive review on genomics, pathways, phenotypic manifestation, and therapeutic targets. Sex Med Rev. 2024 Jun 26;12(3):477-490. doi: 10.1093/sxmrev/qeae006. PMID: 38456235.

Furtado TP, Osadchiy V, Andino JJ, Eleswarapu SV, Mills JN. Collagenase Clostridium histolyticum for Peyronie's disease: a contemporary atlas of complications and their management. Sex Med Rev. 2024 Jun 26;12(3):491-496. doi: 10.1093/sxmrev/qeae004. PMID: 38491199.

Guo Y, Yang Y, Mao Q, Liu H, Wang T, Sun F, Wu J, Cui Y. Efficacy of collagenase Clostridium histolyticum combination therapies for Peyronie's disease: a systematic review and meta-analysis. Sex Med Rev. 2024 Jun 26;12(3):497-504. doi: 10.1093/sxmrev/qeae025. PMID: 38650382.

Burnett AL. Nitric oxide in the penis: still the key erection player? J Sex Med. 2024 Jun 27;21(7):587-588. doi: 10.1093/jsxmed/qdae056. PMID: 38945686.

July

Eslahi A, Ahmed F, Askarpour MR, Nikbakht HA, Shamohammadi I, Ghasemi P, Alimardani H, Ebrahimi B. Outcomes of surgical correction of Peyronie's disease with plaque excision and grafting: Comparison of testicular tunica vaginalis graft versus bovine pericardium graft. Asian J Urol. 2024 Jul;11(3):497-503. doi: 10.1016/j.ajur.2023.03.005. Epub 2023 Aug 2. PMID: 39220831; PMCID: PMC11364893.

Shukla PK, Singh AK, Trivedi S, Dwivedi US, Ramole Y, Khan FA, Pandey M. Role of lingual mucosa as a graft material in the surgical treatment of Peyronie's disease. Urol Ann. 2024 Jul-Sep;16(3):227-232. doi: 10.4103/ua.ua_3_24. Epub 2024 Jul 3. PMID: 39290220; PMCID: PMC11404715.

Corona G, Santi D, Cocci A, Vena W, Pizzocaro A, Vignozzi L, Isidori AM, Pivonello R, Salonia A, Minhas S, Bettocchi C, Reisman Y, Maggi M. Long-term penile prosthesis couple's satisfaction: A systematic review and meta-analysis. Andrology. 2024 Jul 16. doi: 10.1111/andr.13696. Epub ahead of print. PMID: 39010798.

Fratelli L, Klotz C, Spessoto LCF, Facio Junior FN. Peyronie's disease in the early phase: what to do? Rev Assoc Med Bras (1992). 2024 Jul 19;70(7):e20240078. doi: 10.1590/1806-9282.20240078. PMID: 39045934; PMCID: PMC11262318.

Rajamohan N, Kapoor H, Khurana A, Nelson L, Ganesh HS, Khatri G, Nair RT. MR imaging of penile pathology and prostheses. Abdom Radiol (NY). 2024 Jul 27. doi: 10.1007/s00261-024-04417-2. Epub ahead of print. PMID: 39066812.

Osman MM, Hammad MA, Barham DW, Toma R, El-Khatib FM, Dianatnejad S, Nguyen J, Towe M, Choi E, Wu Q, Banavar G, Cai Y, Moura P, Shen N, Vuyisich M, Yafi NR, Yafi FA. Comparison of the gut microbiome composition between men with Peyronie's disease and a matched cohort: a pilot study. Int J Impot Res. 2024 Aug;36(5):531-533. doi: 10.1038/s41443-023-00737-x. Epub 2023 Jul 20. PMID: 37474796.

August

Karakus S, Unal S, Dai D, Joseph C, Du Comb W, Levy JA, Hawksworth D, Burnett AL. Early-onset and uncontrolled diabetes mellitus factors correlate with complications of Peyronie's disease. J Sex Med. 2024 Aug 1;21(:716-722. doi: 10.1093/jsxmed/qdae069. PMID: 38971577.

Du GJ, Xing SY, Wu N, Wang T, Jiang YH, Song T, Yang BB, Dai YT. Injectable agents for the induction of Peyronie's disease in model rats: a comparative study. Asian J Androl. 2024 Aug 13. doi: 10.4103/aja202430. Epub ahead of print. PMID: 39177415.

Douroumis K, Kotrotsios K, Katsikatsos P, Moulavasilis N, Fragkiadis E, Mitropoulos D, Adamakis I. Acute Phase Peyronie's Disease: Where Do We Stand? Cureus. 2024 Aug 17;16(:e67054. doi: 10.7759/cureus.67054. PMID: 39286663; PMCID: PMC11403542.

Minore A, Cacciatore L, Presicce F, Iannuzzi A, Testa A, Raso G, Papalia R, Martini M, Scarpa RM, Esperto F. Intralesional and topical treatments for Peyronie's disease: a narrative review of current knowledge. Asian J Androl. 2024 Aug 23. doi: 10.4103/aja202460. Epub ahead of print. PMID: 39177048.

Eslami S, Tahmasbi F, Rahimi-Mamaghani A, Sanaie S, Bettocchi C, Sedigh O, Soleimanzadeh F. Investigating iontophoresis as a therapeutic approach for Peyronie's disease: a systematic review. Sex Med Rev. 2024 Aug 26:qeae058. doi: 10.1093/sxmrev/qeae058. Epub ahead of print. PMID: 39186947.

Hawks-Ladds N, Babar M, Labagnara K, Loloi J, Patel RD, Aalami Harandi A, Zhu M, Salami A, Maria P. Risk factors for reoperation of inflatable penile prosthesis among an ethnically diverse urban population in a high-volume center. Int J Impot Res. 2024 Aug 26. doi: 10.1038/s41443-024-00966-8. Epub ahead of print. PMID: 39187572.

[bentoboy]

September

Dullea A, Khodamoradi K, Campbell K, Ghomeshi A, Ramasamy R, Ziegelmann M, Masterson T. In vitro efficacy of intralesional Collagenase Clostridium Histolyticum for the treatment of calcified Peyronie's disease plaques. Int J Impot Res. 2024 Sep;36(6):572-575. doi: 10.1038/s41443-023-00742-0. Epub 2023 Jul 31. PMID: 37524836.

Yang X, Wu J, Cai T, Shan J, Cui Y. Kindlin-2 mediates Peyronie's disease through activation of TGF-β/Smad signaling pathway under the presence of TGF-β1. Cell Signal. 2024 Sep;121:111286. doi: 10.1016/j.cellsig.2024.111286. Epub 2024 Jul 6. PMID: 38977232.

Trost L, Mulhall J, Hellstrom W. Creation of a Novel Classification System (PTNM) for Peyronie's Disease and Penile Curvature Using Evidence-Based Criteria. J Urol. 2024 Sep;212(3):470-482. doi: 10.1097/JU.0000000000004072. Epub 2024 Aug 8. PMID: 39115123.

García Rojo E, Kollitsch L, García Gómez B, Alonso Isa M, Romero Otero J, Moncada I, Osmonov D. The role of imaging in patients with corporal fibrosis undergoing penile prosthesis placement: a narrative review. Rev Int Androl. 2024 Sep;22(3):1-8. doi: 10.22514/j.androl.2024.016. Epub 2024 Sep 30. PMID: 39394743.

Warren CJ, Edmonds VS, Payne NG, Voletti S, Wu SY, Colquitt J, Sadeghi-Nejad H, Punjani N. Prompt matters: evaluation of large language model chatbot responses related to Peyronie's disease. Sex Med. 2024 Sep 9;12(4):qfae055. doi: 10.1093/sexmed/qfae055. PMID: 39257694; PMCID: PMC11384107.

Henningsohn L, Larsson H, Kuja-Halkola R, Cederlöf M. Risk of relationship separation in men with Peyronie's disease in a matched Swedish cohort. Sci Rep. 2024 Sep 10;14(1):21143. doi: 10.1038/s41598-024-72390-3. PMID: 39256558; PMCID: PMC11387766.

Dell'Atti L, Slyusar V, Ronchi P, Cambise C. Vacuum Erection Device Plus Once-Daily Tadalafil Improve Clinical Outcomes after Extracorporeal Shock Wave Therapy in Men Affected by Erectile Dysfunction Associated with Peyronie's Disease. Life (Basel). 2024 Sep 13;14(9):1162. doi: 10.3390/life14091162. PMID: 39337945; PMCID: PMC11432888.

Lewis K, DeAngelo L, Raheem O, Bole R. The Emerging Role of Artificial Intelligence and Automated Platforms for the Assessment of Penile Curvature: A Scoping Review. Curr Urol Rep. 2024 Sep 20;26(1):2. doi: 10.1007/s11934-024-01232-6. PMID: 39302528; PMCID: PMC11415446.

Furtado TP, Osadchiy V, Eleswarapu SV. The Promise of Artificial Intelligence in Peyronie's Disease. Curr Urol Rep. 2024 Sep 21;26(1):3. doi: 10.1007/s11934-024-01233-5. PMID: 39305366; PMCID: PMC11416409.

Tienforti D, Hoxha M, Di Pasquale AB, Rizza V, Barbonetti A. Analysis of evidence on nutraceutical interventions for Peyronie's disease: a guideline-based critical review. Sex Med Rev. 2024 Sep 25;12(4):747-753. doi: 10.1093/sxmrev/qeae038. PMID: 38807529.

October

Dell'Atti L, Slyusar V, Cambise C. Multimodal treatments based on Tadalafil during acute phase of Peyronie's disease: experience at two referral academic centers. Ir J Med Sci. 2024 Oct;193(5):2301-2306. doi: 10.1007/s11845-024-03734-1. Epub 2024 Jun 11. PMID: 38861101.

Paulis G, De Giorgio G, Paulis A. Combining ultrasound and elastography for the detection of a non-palpable, non-sonographically visualized Peyronie's plaques. Our experience. Arch Ital Urol Androl. 2024 Oct 2;96(3):12690. doi: 10.4081/aiua.2024.12690. PMID: 39356014.

Chan JYH, Alhamam A, Witherspoon L, Rivers JK, Flannigan RK. Fractional CO2 laser for the treatment of Peyronie's disease: A pilot clinical trial. Can Urol Assoc J. 2024 Oct 7. doi: 10.5489/cuaj.8852. Epub ahead of print. PMID: 39418492.

Li G, Xu X, Man L. Low-intensity extracorporeal shock wave therapy for Peyroniès disease: a systematic review and meta-analysis. BMC Urol. 2024 Oct 8;24(1):217. doi: 10.1186/s12894-024-01607-4. PMID: 39375617; PMCID: PMC11459888.

Garaz R, Amend B, Stenzl A, Bedke J, Hennenlotter J, Rochwarger A, Schürch CM, Tsaur I, Rausch S. Collagen fleece grafting for surgical treatment of patients with mild to severe peyronie's curvatures. Int Urol Nephrol. 2024 Oct 8. doi: 10.1007/s11255-024-04222-2. Epub ahead of print. PMID: 39377995.

Hricz N, Schlidt K, Ha M, Er S, Stark K, Jung E, Liang F, Rasko YM. A review of Peyronie's disease insurance coverage. Sex Med. 2024 Oct 24;12(5):qfae071. doi: 10.1093/sexmed/qfae071. PMID: 39450208; PMCID: PMC11500605.

Kim DS, Yang HJ, Jeong HC, Moon KH, Lee DS, Song SH, Lee WK; Korean Society for Sexual Medicine and Andrology Clinical Practice Guideline Committee. Diagnosis and Management of Peyronie's Disease: A Clinical Consensus Statement and Recommendations from the Korean Society for Sexual Medicine and Andrology. World J Mens Health. 2024 Oct 25. doi: 10.5534/wjmh.240200. Epub ahead of print. PMID: 39478653.

Mian AH, Ziegelmann MJ. Current and Future Directions of Technology in Assessment of Peyronie's Disease. Curr Urol Rep. 2024 Oct 29;26(1):15. doi: 10.1007/s11934-024-01247-z. PMID: 39470953.

Paulis G, De Giorgio G, Paulis A. Healing of Peyronie's disease after multimodal antioxidant treatment. A case series. Arch Ital Urol Androl. 2024 Oct 29;96(4):12956. doi: 10.4081/aiua.2024.12956. PMID: 39692418.

Altieri VM, Saldutto P, Verratti V, La Rocca R, Di Mauro E, Celentano G, Capece M, Morgera V, Cacace G, Vena W, Mastrangelo F, Napolitano L, Iacono F. Altieri modified Nesbit corporoplasty for the treatment of penile curvature: Comparison of local anesthesia vs loco-regional anesthesia on the clinical outcomes. Arch Ital Urol Androl. 2024 Oct 29;96(4):12957. doi: 10.4081/aiua.2024.12957. PMID: 39692419.

[bentoboy]

November

Miller JA, Hammad M, Amini E, Andrianne R, Burnett AL, Gross K, Gross MS, Hatzichristodoulou G, Hotaling J, Hsieh TC, Jenkins LC, Jones JM, Lentz A, Levy J, Modgil V, Osmonov D, Park SH, Pearce I, Perito P, Sadeghi-Nejad H, Sempels M, Simhan J, Suarez-Sarmiento A Jr, van Renterghem K, Warner JN, Yafi FA, Ziegelmann M, Barham DW. Factors Affecting Implant Length in Primary Inflatable Penile Prosthesis Placement. Urology. 2024 Nov;193:240-244. doi: 10.1016/j.urology.2024.06.068. Epub 2024 Jul 5. PMID: 38972393.

Crisostomo-Wynne T, Hertz A, Maloney T, Walter J, Caras RJ. Use of thermographic imaging for the evaluation of erectile dysfunction and Peyronie's disease. Int J Impot Res. 2024 Nov;36(7):755-758. doi: 10.1038/s41443-024-00950-2. Epub 2024 Jul 14. PMID: 39004622.

Mesquita FC, Barros R, Lima TFN, Velasquez D, Favorito LA, Pozzi E, Dornbush J, Miller D, Petrella F, Ramasamy R. Evidence of restorative therapies in the treatment of Peyronie disease: A narrative review. Int Braz J Urol. 2024 Nov-Dec;50(6):703-713. doi: 10.1590/S1677-5538.IBJU.2024.9920. PMID: 39133793; PMCID: PMC11554274.

Schlager D, Leiber-Caspers C. Neue ,,konservative" Therapien bei der Induratio penis plastica (IPP) – echte Alternativen oder teurer Zeitvertreib? [New "conservative" treatments for Peyronie's disease-real alternatives or expensive pastime?]. Urologie. 2024 Nov;63(11):1097-1102. German. doi: 10.1007/s00120-024-02453-w. Epub 2024 Oct 9. PMID: 39384594.

Lethuillier V, Peyronnet B, Richard C, Bensalah CK, Mathieu R, Robin F, Faix A, Roux JL, Freton L. When fibrosis intersect: Association and risk factors between Peyronie's and Dupuytren's diseases. Fr J Urol. 2024 Nov;34(14):102759. doi: 10.1016/j.fjurol.2024.102759. Epub 2024 Oct 18. PMID: 39426569.

Moon DG, Cho SB, Hwang WK, Kim HJ, Ahn ST. Postoperative Progress of Deep Grid Incision and Sealing with Collagen Fleece for Treatment of Peyronie's Disease: Prospective Observational Study for 3 Years. World J Mens Health. 2024 Nov 6. doi: 10.5534/wjmh.240201. Epub ahead of print. PMID: 39536768.

Broderick GA, Mills JN, Bathish L, Davis C, Khera M. Development of a new Peyronie's disease self-assessment screening app. Transl Androl Urol. 2024 Nov 30;13(11):2617-2624. doi: 10.21037/tau-24-273. Epub 2024 Nov 28. PMID: 39698562; PMCID: PMC11650355.

December

Preto M, Falcone M, Plamadeala N, Schifano N, Bettocchi C, Colombo F, Fiordelise S, Vitarelli A, Silvani M, Mondaini N, Paradiso M, Ceruti C, Varvello F, Palumbo F, Avolio A, Antonini G, Corvasce A, Pozza D, Franco G, Bitelli M, Boezio F, Conti E, Caraceni E, Negro C, Carrino M, Vicini P, Ghidini N, Alei G, Italiano E, Timpano M, Polito M, Natali A, Tamai A, Pescatori E, Dehò F, Gideon B, Gontero P, Palmieri A, Capogrosso P. Risk of unfavorable outcomes after penile prosthesis implantation - results from a national registry (INSIST-ED). Int J Impot Res. 2024 Dec;36(:842-847. doi: 10.1038/s41443-023-00784-4. Epub 2023 Oct 31. PMID: 37907669.

Garaffa G, Traunero F, Claps F, Pavan N, Rossin G, Piasentin A, Rizzo M, Biasatti A, Zorzi F, Trombetta C, Liguori G, Ongaro L. Plication surgery does not produce additional loss of length in Peyronie's disease patients. Int J Impot Res. 2024 Dec;36(:869-872. doi: 10.1038/s41443-024-00852-3. Epub 2024 Feb 22. PMID: 38388784.

Ledesma BR, Velasquez DA, Egemba C, Molina M, Ibrahim E, Costantini-Mesquita F, Deebel NA, Han S, Reis IM, Saltzman R, Ramasamy R. A phase 2 randomized, placebo-controlled crossover trial to evaluate safety and efficacy of platelet-rich plasma injections for Peyronie's disease: clinical trial update. Int J Impot Res. 2024 Dec;36(:813-817. doi: 10.1038/s41443-024-00844-3. Epub 2024 Feb 29. PMID: 38424354.

Şahin A, Babayev H, Cirigliano L, Preto M, Falcone M, Altıntas E, Gül M. Unveiling the molecular Hallmarks of Peyronie's disease: a comprehensive narrative review. Int J Impot Res. 2024 Dec;36(:801-808. doi: 10.1038/s41443-024-00845-2. Epub 2024 Mar 7. PMID: 38454161.

Trost L. An illustrated description of a modified collagenase Clostridium histolyticum protocol for Peyronie's disease. J Sex Med. 2024 Dec 1;21(12):1169-1177. doi: 10.1093/jsxmed/qdae134. PMID: 39667078.

Bal KS, Achalu P, Okene MO, Krug A, Hsieh TC, Mirheydar H. Impact of the Advent of Collagenase Clostridium histolyticum on the Surgical Management of Peyronie's Disease: A Population-Based Analysis. Perm J. 2024 Dec 6:1-7. doi: 10.7812/TPP/24.135. Epub ahead of print. PMID: 39639714.

Okene MO, Achalu P, Hsieh TC, Mirheydar H. Impact of Race and Ethnicity on Clinical Outcomes of Collagenase Clostridium histolyticum in Patients With Peyronie's Disease Across Kaiser Permanente Southern California Database. Perm J. 2024 Dec 12:1-8. doi: 10.7812/TPP/24.111. Epub ahead of print. PMID: 39663827.

Song J, Saffati G, Dai M, Naeem T, Lipshultz L, Khera M. Long-Term Satisfaction With Collagenase Clostridium Histolyticum for Peyronie's Disease: Clinical Predictors and Side Effect Profile. Urol Pract. 2025 Jan;12(1):168-175. doi: 10.1097/UPJ.0000000000000696. Epub 2024 Sep 3. PMID: 39241009.

[Pfract]

Thank you for all that you do, Bentoboy!

How do you feel about posting the link to where you source these most recent studies? I assume you find most of them in places like PubMed or Sciencedirect?

[bentoboy]

No worries, I'm happy that it could be useful for some people here. Actually, that's a good suggestion - let me add some links next time, it would make it easier for everyone!

Yeah, usually I look for new articles on PubMed!